Anne Chalumeau
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the HBG1/2 promoters.
Journal: Molecular therapy. Nucleic acids
Published: October 08, 2025
Results from the T2K Experiment on Neutrino Mixing Including a New Far Detector μ-like Sample.
Journal: Physical review letters
Published: June 12, 2025
First Measurement of the Electron-Neutrino Charged-Current Pion Production Cross Section on Carbon with the T2K Near Detector.
Journal: Physical review letters
Published: May 19, 2025
Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease.
Journal: Cell reports. Medicine
Published: May 15, 2025
Cyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease.
Journal: Human gene therapy
Published: November 06, 2024
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease.
Journal: Nature communications
Published: August 14, 2024
First Joint Oscillation Analysis of Super-Kamiokande Atmospheric and T2K Accelerator Neutrino Data.
Journal: Physical review letters
Published: May 22, 2024
Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 26, 2024
Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.
Journal: Nature communications
Published: August 08, 2023
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.
Journal: Molecular therapy. Nucleic acids
Published: July 30, 2022
Last Updated: 09/26/2026